top of page
info@maxwellia.com
Lovima
About
Team
Our network
Unique
Pipeline
Partner
Pharmacy
Distribute
Capability
Investors
Invest in Maxwellia
News
Lovima Launch July 2021
Aquiette PR April 2022
Contact
More
Use tab to navigate through the menu items.
INTRODUCING LOVIONE®
A NEW BRAND OF EMERGENCY CONTRACEPTION
Read more
SWITCH UP TO SELF-CARE:
SELF-CARE DAY 2023
Read more
AI INFLUENCER TACKLES TIKTOK HEALTH TREND
Read more
CONTRACEPTION IN PHARMACY.
WHY WAIT?
MAY 2023
Read more
MHRA DECISION ON AQUIETTE RECLASSIFICATION
MAY 2023
Read more
WORLD PHARMACISTS DAY 2022:
PHARMACY IN ACTION FOR A HEALTHIER WORLD
Read more
MAXWELLIA CEO, ANNA MAXWELL HAS BEEN APPOINTED A FELLOW OF THE ROYAL PHARMACEUTICAL SOCIETY
Read more
FORMER PHARMACY SUPERINTENDENT JANICE PERKINS RESPONDS TO AQUIETTE PUBLIC CONSULTATION
®
Read more
MAXWELLIA CEO ANNA MAXWELL MEETS SECRETARY OF STATE,
LIZ TRUSS
Read more
PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S SECOND WOMEN’S HEALTH PRODUCT
Read more
DR JULIAN SPINKS RESPONDS TO AQUIETTE PUBLIC CONSULTATION – FOR HEALTH CARE PROFESSIONALS
®
Read more
IAN ADAMSON JOINS MAXWELLIA AS STRATEGIC ADVISOR
Read more
MAXWELLIA UNVEILS BOLD £3M 360° SUPPORT CAMPAIGN TO DRIVE AWARENESS OF ITS CONTRACEPTIVE PILL LOVIMA
®
Read more
CHANNEL 4 VENTURES INVESTS IN MAXWELLIA – THE LEADING MEDICINES SWITCH COMPANY
Read more
APPOINTMENT OF
SARA AL-ATTBI AS
MEDICAL AFFAIRS PHARMACIST
Read more
GAME CHANGER
Anna Maxwell, the founder and CEO of Maxwellia, tells Breakthrough how her pioneering business will widen access to medicine.
Read more
PUSHING THE ON SWITCH
New brands , new pharmacy categories. Next... watch this space.
Read more
WOMEN CAN BUY MAXWELLIA’S LOVIMA
®
CONTRACEPTIVE PILL FROM PHARMACIES WITHOUT A PRESCRIPTION FOR FIRST TIME IN UK HISTORY
Wider availability of desogestrel welcomed by UK’s leading women’s health organisations
Read more
MAXWELLIA MAKES ‘MOST EXCITING COMPANIES’ LIST IN NORTH WEST BUSINESS INSIDER MAGAZINE
Read more
POWERING UP PHARMACIES
How the High Street hubs can help futureproof the NHS
Read more
MAXWELLIA SECURES £500K BRITISH GOVERNMENT BACKED FUTURE FUND INVESTMENT
Read more
PRAETURA LEADS SELF CARE FIRM INVESTMENT ROUND
Read more
PUBLIC CONSULTATION ANNOUNCED FOR MAXWELLIA’S FIRST WOMEN’S HEALTH PRODUCT
Read more
OUR CEO TALKS TO HBW INDUSTRY INSIGHT ABOUT MAXWELLIA’S TRANSITION INTO A CONSUMER HEALTHCARE COMPANY
Read more
BIOCITY FEATURE MAXWELLIA CEO ON IWD 2021 CHALLENGING ACCESS TO CONTRACEPTION
Read more
SPEARHEADING SHIFT TO SELF CARE WITH THREE PHARMACY PRODUCTS IN LAUNCH PIPELINE
Pharmacists at heart of nation's public health
Read more
APPOINTMENT OF PARESH BALDANIYA AS HEAD OF QUALITY & REGULATORY AFFAIRS
Paresh has a pharmacy background and a stellar track record
Read more
APPOINTMENT OF JACK GRIMSHAW AS FINANCE DIRECTOR
Jack brings to Maxwellia more than 10 years of finance experience across a range of industries
Read more
TOP MOVER AND SHAKER IN BIOBUSINESS 2019
Our CEO and founder, Anna Maxwell has been listed in the top 50 movers and shakers of 2019 by BioBusiness
Read more
BIOCITY INVESTS IN MAXWELLIA
Life science incubator and business collective BioCity has announced an investment in Alderley Park-based Maxwellia
Read more
POM TO P SWITCHES: WHAT MADE MALOFF PROTECT AND ELLAONE A SUCCESS?
C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of Maxwellia, about what makes a successful POM to P change
Read more
MAXWELLIA MEETS THE HEALTH SECRETARY
Maxwellia had the opportunity to put the switch agenda on the radar of Matt Hancock, Secretary of State for Health and Social Care
Read more
THE POWER OF ALIGNING YOUR BUSINESS TO A GLOBAL GOAL
Maxwellia is mentioned in Forbes for aligning to Global Goal 3 Good Health
Read more
MAXWELLIA EXPANDS TEAM OF SWITCH EXPERTS AS IT BUILDS THE PRODUCT PIPELINE
Appointments will expedite conversion of prescription medicines to over the counter
Read more
UK IS FERTILE GROUND FOR SWITCHING
With the recent switch of Pfizer’s Viagra, the UK has shown itself to be an open and progressive market for prescription-to-OTC reclassification.
Read more
MAXWELLIA ANNOUNCES FUNDING TO ACCELERATE ITS MISSION FOR SELF CARE
Investment will expedite conversion of prescription medicines to over the counter
Read more
bottom of page
